Longeveron(LGVN)

Search documents
Longeveron(LGVN) - 2022 Q4 - Earnings Call Transcript
2023-03-10 23:40
Longeveron Inc. (NASDAQ:LGVN) Q4 2022 Results Conference Call March 10, 2023 8:30 AM ET Company Participants James Clavijo - CFO Wa’el Hashad - CEO Dr. Chris Min - Chief Medical Officer Conference Call Participants Michael Okunewitch - Maxim Group Operator Good morning, and welcome to Longeveron's call today to discuss the company's 2022 Fourth Quarter and Full Year Financial Results. [Operator Instructions] I would now like to turn the call over to James Clavijo, Longeveron's Chief Financial Officer. James ...
Longeveron(LGVN) - 2022 Q3 - Quarterly Report
2022-11-14 21:02
For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 001-40060 Longeveron Inc. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (State or Other Jurisdiction of Incorporation) ...
Longeveron(LGVN) - 2022 Q3 - Earnings Call Transcript
2022-11-14 15:39
Longeveron Inc. (NASDAQ:LGVN) Q3 2022 Earnings Conference Call November 14, 2022 8:30 AM ET Company Representatives Dr. Chris Min - Interim Chief Executive Officer, Chief Medical Officer Dr. Joshua Hare - Co-Founder, Chief Science Officer, Chairman James Clavijo - Chief Financial Officer Elsie Yau - Stern Investor Relations Conference Call Participants Michael Okunewitch - Maxim Group Operator Good morning or good afternoon, and welcome to the Longeveron Inc., 2022 Third Quarter Earnings Call. My name is Aj ...
Longeveron (LGVN) Investor Presentation - Slideshow
2022-09-14 13:40
| --- | --- | --- | --- | --- | |---------------------------------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Cell-Based Therapies | | | | | | | | | | | | A Regenerative Medicine Company | | | | | | September 2022 | | | | | Forward Looking Statements Certain statements in this presentation that are not historical facts are forward-looking statements that reflect management's current expectations, assumptions, and estimates of future performance and economi ...
Longeveron(LGVN) - 2022 Q2 - Earnings Call Transcript
2022-08-14 06:02
Longeveron Inc. (NASDAQ:LGVN) Q2 2022 Earnings Conference Call August 12, 2022 8:30 AM ET Company Participants Elsie Yau - Stern Investor Relations Chris Min - Interim Chief Executive Officer & Chief Medical Officer James Clavijo - Chief Financial Officer Joshua Hare - Co-Founder, Chief Science Officer & Chairman Conference Call Participants Michael Okunewitch - Maxim Group Operator Ladies and gentlemen, thank you for standing by. Welcome to the Longeveron 2022 Second Quarter Earnings Call. My name is Irene ...
Longeveron(LGVN) - 2022 Q2 - Quarterly Report
2022-08-12 20:01
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 001-40060 Longeveron Inc. (Exact name of registrant as specified in its charter) (State or Other Jurisdiction of Incorporation) Dela ...
Longeveron(LGVN) - 2022 Q1 - Earnings Call Transcript
2022-05-17 18:16
Longeveron Inc. (NASDAQ:LGVN) Q1 2022 Earnings Conference Call May 13, 2022 8:30 AM ET Company Participants Elsie Yau - Stern Investor Relations, IR Geoff Green - CEO Chris Min - Chief Medical Officer James Clavijo - CFO Joshua Hare - Chief Science Officer Conference Call Participants Michael Okunewitch - Maxim Group Constantine Davides - EF Hutton Operator Hello everyone and welcome to the Longeveron Inc. 2022 First Quarter Earnings Call. My name is Juan and I will be coordinating your call today. All part ...
Longeveron(LGVN) - 2022 Q1 - Quarterly Report
2022-05-13 20:06
For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38295 Longeveron Inc. (Exact name of registrant as specified in its charter) | Delaware | 001-40060 | 47-2174146 | (State or Ot ...
Longeveron(LGVN) - 2021 Q4 - Annual Report
2022-03-11 22:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40060 LONGEVERON INC. (Exact name of registrant as specified in its charter) Delaware 47-2174146 (State or Other Jurisdiction of Inc ...
Longeveron(LGVN) - 2021 Q4 - Earnings Call Transcript
2022-03-11 21:50
Longeveron Inc. (NASDAQ:LGVN) Q4 2021 Results Conference Call March 11, 2022 8:30 AM ET Company Participants Brendan Payne - Stern IR Geoff Green - Chief Executive Officer Dr. Joshua Hare - Co-Founder, Chief Science Officer and Chairman James Clavijo - Chief Financial Officer Operator Hello and welcome to Longeveron's call today to discuss the Company's 2021 Fourth Quarter and Year-End Financial Results. All participants are currently in a listen-only mode. Following the formal presentation, we will open th ...